These findings suggest a sex-specific susceptibility, indicating that women may be at a higher risk of HSV infection when treated with GLP-1RA compared to DPP-4i
While they are often discussed in the context of weight loss, their origins (and their impact) are rooted in deeper biological systems that regulate appetite, blood sugar, and energy balance
These fibrosarcomas were attributed to the high local concentration of drug near the injection site
The Difference Matters Patients with Type 2 diabetes face different health considerations than otherwise healthy individuals seeking weight loss: Diabetes Patients: Already managing a chronic condition requiring medical monitoring Regular appointments with healthcare providers to track blood sugar Typically use lower doses focused on glucose control May have other diabetes medications that interact with GLP-1 drugs Often have existing gastrointestinal issues from diabetes itself Weight Management Patients: Often healthy individuals without chronic conditions May use higher doses prescribed specifically for weight loss Less frequent medical monitoring No existing reason to expect severe health complications Prescribed Ozempic off-label without FDA approval for this use When pharmaceutical companies aggressively marketed Ozempic for weight management despite FDA approval only for diabetes treatment, they expanded the population exposed to serious adverse effects
For those with a strong tendency towards obesity, typical diet and exercise may yield short-lived results
You can find further information about Farxigas side effects in this comprehensive article
.png)
